Clinical trial
Telomerase Activator and Retinal Amyloid
NCT02530255
Study timeline
Study start (actual)2016-12-01Date precision: day
Registry last updated2019-07-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer Diseaseverified · MONDO: Alzheimer disease
Interventions
cycloastragenolDIETARY_SUPPLEMENT
placebo (for cycloastragenol)DIETARY_SUPPLEMENT
Sponsors & collaborators
Chippewa Valley Eye Cliniclead sponsor
TA-Sciencescollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02530255 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.